Sensorimotor Function in COPD

NCT07825636 | Completed

• 1 other identifier: 2024/04
• Study Type: observational
• Target: 95
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study was to investigate the level of sensorimotor function impairment according to disease stage in individuals with Chronic Obstructive Pulmonary Disease (COPD) and to determine whether functional differences exist between individuals with COPD and healthy controls.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Keywords

Muscle dysfunction; Proprioception; Pain; Cognitive impairment

Outcome Measures

Primary Outcomes (3)

• Montreal Cognitive Assessment

  Cognitive function was assessed using the Montreal Cognitive Assessment. The scale evaluates various cognitive domains, such as executive functions, visuospatial skills, attention, memory, language, abstraction, and orientation. The total score was calculated out of 30 points.

  Enrollment

• Pain Pressure Threshold and Tolerance

  Pain threshold and pain tolerance were assessed using a digital pressure algometer (J-Tech Commander algometer, Preston Co., USA). Two measurements were taken from each site, and the mean value was used in the analysis.

  Enrollment

• Muscle Quality Index

  Muscle quality was assessed using the Muscle Quality Index, calculated based on the duration of the 5-repetition sit-to-stand test, body weight, and leg length.

  Enrollment

Secondary Outcomes (1)

• Lower Extremity Coordination Test

  Enrollment

Study Arms (2)

COPD Group

Healthy Control

Eligibility Criteria

• Age: 40 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Individuals diagnosed with COPD or healthy controls between the age of 40-65 years.

You may qualify if:

• Individuals diagnosed with COPD,
• Aged 40-65 years, who volunteer to participate in the study,
• Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems, or respiratory failure (not using long-term home oxygen therapy or non-invasive mechanical ventilation) will be included.
• Individuals aged 40-65 years who volunteer to participate in the study,
• Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems,
• Who do not have communication problems will be included.

You may not qualify if:

• Individuals with uncorrected visual and hearing impairment,
• Individuals with a diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.).
• Individuals with uncorrected visual and hearing impairment,
• A diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.) will be excluded from the study.

Sponsors & Collaborators

• Alanya Alaaddin Keykubat University: lead

Study Sites (1)

Alanya Alaaddin Keykubet University

Antalya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Pain; Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Neurologic Manifestations; Signs and Symptoms; Cognition Disorders; Neurocognitive Disorders; Mental Disorders

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assoc. Prof, PT.PhD.

Study Record Dates

• First Submitted: September 6, 2026
• First Posted: September 17, 2026
• Study Start: October 1, 2024
• Primary Completion: May 1, 2026
• Study Completion: July 1, 2026
• Last Updated: September 17, 2026

Record last verified: 2026-09

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)